SCHEMBL8612254

SCHEMBL8612254

N#Cc1ccc(C(N)=O)c(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 1/20 0.50
▸ TMPRSS4 Q9NRS4 1/20 0.45
▸ P4HB P07237 2/20 0.43
▸ MRGPRX4 Q96LA9 1/20 0.42
▸ CES2 O00748 1/20 0.42
▸ KIF11 P52732 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ SCN9A Q15858 2/20 0.40
▸ PARP15 Q460N3 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.39
▸ PARP2 Q9UGN5 1/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ XDH P47989 1/20 0.38
▸ SLC22A12 Q96S37 1/20 0.38
▸ IKBKB O14920 1/20 0.37
▸ CHUK O15111 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417702 0.86 TRPV4 (0.53) TRPV4TMPRSS4P4HBMRGPRX4CES2
SCHEMBL7566278 0.85 P4HB (0.46) TRPV4TMPRSS4P4HBMRGPRX4PARP15
SCHEMBL23370123 0.83 TRPV4 (0.50) TRPV4TMPRSS4P4HBMRGPRX4CES2
SCHEMBL26020582 0.81 TRPV4 (0.51) TRPV4TMPRSS4P4HBMRGPRX4CES2
SCHEMBL1417558 0.80 TMPRSS4 (0.48) TRPV4TMPRSS4P4HBMRGPRX4CES2
SCHEMBL3176877 0.77 DGAT1 (0.55) CASP1PARP15PARP10PARP2PARP1
SCHEMBL1417596 0.77 TRPV4 (0.48) TRPV4TMPRSS4P4HBMRGPRX4CES2
SCHEMBL24152864 0.77 TRPV4 (0.46) TRPV4TMPRSS4P4HBMRGPRX4CES2
SCHEMBL2956919 0.76 HRH4 (0.40) TMPRSS4MRGPRX4CASP1SCN9APARP15
SCHEMBL6554547 0.76 SMO (0.45) TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026801-A1 SSAO INHIBITORS AND USE THEREOF ECCOGENE INC. 2023-01-26 — — US disclosed
US-5747539-A Fluorine-containing benzoylguanidines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026801-A1 SSAO INHIBITORS AND USE THEREOF SSB, HAO1, SORD TRPV4 2555/4885TMPRSS4 817/4885P4HB 1301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback